304 related articles for article (PubMed ID: 28362827)
1. Alzheimer's amyloid-β A2T variant and its N-terminal peptides inhibit amyloid-β fibrillization and rescue the induced cytotoxicity.
Lin TW; Chang CF; Chang YJ; Liao YH; Yu HM; Chen YR
PLoS One; 2017; 12(3):e0174561. PubMed ID: 28362827
[TBL] [Abstract][Full Text] [Related]
2. Amyloid β-Protein Assembly: Differential Effects of the Protective A2T Mutation and Recessive A2V Familial Alzheimer's Disease Mutation.
Zheng X; Liu D; Roychaudhuri R; Teplow DB; Bowers MT
ACS Chem Neurosci; 2015 Oct; 6(10):1732-40. PubMed ID: 26244608
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer's protective A2T mutation changes the conformational landscape of the Aβ₁₋₄₂ monomer differently than does the A2V mutation.
Das P; Murray B; Belfort G
Biophys J; 2015 Feb; 108(3):738-47. PubMed ID: 25650940
[TBL] [Abstract][Full Text] [Related]
4. The Pathogenic A2V Mutant Exhibits Distinct Aggregation Kinetics, Metal Site Structure, and Metal Exchange of the Cu
Somavarapu AK; Shen F; Teilum K; Zhang J; Mossin S; Thulstrup PW; Bjerrum MJ; Tiwari MK; Szunyogh D; Søtofte PM; Kepp KP; Hemmingsen L
Chemistry; 2017 Oct; 23(55):13591-13595. PubMed ID: 28815875
[TBL] [Abstract][Full Text] [Related]
5. Dimerization Mechanism of Alzheimer Aβ
Nguyen PH; Sterpone F; Pouplana R; Derreumaux P; Campanera JM
J Phys Chem B; 2016 Dec; 120(47):12111-12126. PubMed ID: 27933940
[TBL] [Abstract][Full Text] [Related]
6. A2T and A2V Aβ peptides exhibit different aggregation kinetics, primary nucleation, morphology, structure, and LTP inhibition.
Murray B; Sorci M; Rosenthal J; Lippens J; Isaacson D; Das P; Fabris D; Li S; Belfort G
Proteins; 2016 Apr; 84(4):488-500. PubMed ID: 26799157
[TBL] [Abstract][Full Text] [Related]
7. Amyloid Modifier SERF1a Accelerates Alzheimer's Amyloid-β Fibrillization and Exacerbates the Cytotoxicity.
Tsai TY; Jhang WT; Hsu HK; Chan YT; Chang CF; Chen YR
ACS Chem Neurosci; 2024 Feb; 15(3):479-490. PubMed ID: 38211979
[TBL] [Abstract][Full Text] [Related]
8. The Alzheimer disease protective mutation A2T modulates kinetic and thermodynamic properties of amyloid-β (Aβ) aggregation.
Benilova I; Gallardo R; Ungureanu AA; Castillo Cano V; Snellinx A; Ramakers M; Bartic C; Rousseau F; Schymkowitz J; De Strooper B
J Biol Chem; 2014 Nov; 289(45):30977-89. PubMed ID: 25253695
[TBL] [Abstract][Full Text] [Related]
9. Emergence of Alternative Structures in Amyloid Beta 1-42 Monomeric Landscape by N-terminal Hexapeptide Amyloid Inhibitors.
Chakraborty S; Das P
Sci Rep; 2017 Aug; 7(1):9941. PubMed ID: 28855598
[TBL] [Abstract][Full Text] [Related]
10. Effect of Alzheimer's Disease Causative and Protective Mutations on the Hydration Environment of Amyloid-β.
Aggarwal L; Biswas P
J Phys Chem B; 2020 Mar; 124(12):2311-2322. PubMed ID: 32130011
[TBL] [Abstract][Full Text] [Related]
11. Modulation in the conformational and stability attributes of the Alzheimer's disease associated amyloid-beta mutants and their favorable stabilization by curcumin: molecular dynamics simulation analysis.
Awasthi M; Singh S; Pandey VP; Dwivedi UN
J Biomol Struct Dyn; 2018 Feb; 36(2):407-422. PubMed ID: 28054501
[TBL] [Abstract][Full Text] [Related]
12. Weaker N-Terminal Interactions for the Protective over the Causative Aβ Peptide Dimer Mutants.
Sharma B; Ranganathan SV; Belfort G
ACS Chem Neurosci; 2018 Jun; 9(6):1247-1253. PubMed ID: 29465978
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation at Ser
Hu ZW; Ma MR; Chen YX; Zhao YF; Qiang W; Li YM
J Biol Chem; 2017 Feb; 292(7):2611-2623. PubMed ID: 28031462
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of the Interactions between Copper and Amyloid-β with FAD Mutations and Phosphorylation at the N terminus.
Girvan P; Miyake T; Teng X; Branch T; Ying L
Chembiochem; 2016 Sep; 17(18):1732-7. PubMed ID: 27356100
[TBL] [Abstract][Full Text] [Related]
15. Alzheimer's Protective Cross-Interaction between Wild-Type and A2T Variants Alters Aβ
Das P; Chacko AR; Belfort G
ACS Chem Neurosci; 2017 Mar; 8(3):606-618. PubMed ID: 28292185
[TBL] [Abstract][Full Text] [Related]
16. The coexistence of an equal amount of Alzheimer's amyloid-β 40 and 42 forms structurally stable and toxic oligomers through a distinct pathway.
Chang YJ; Chen YR
FEBS J; 2014 Jun; 281(11):2674-87. PubMed ID: 24720730
[TBL] [Abstract][Full Text] [Related]
17. Dual effects of familial Alzheimer's disease mutations (D7H, D7N, and H6R) on amyloid β peptide: correlation dynamics and zinc binding.
Xu L; Chen Y; Wang X
Proteins; 2014 Dec; 82(12):3286-97. PubMed ID: 25137638
[TBL] [Abstract][Full Text] [Related]
18. Abeta20-29 peptide blocking apoE/Abeta interaction reduces full-length Abeta42/40 fibril formation and cytotoxicity in vitro.
Hao J; Zhang W; Zhang P; Liu R; Liu L; Lei G; Su C; Miao J; Li Z
Neuropeptides; 2010 Aug; 44(4):305-13. PubMed ID: 20363024
[TBL] [Abstract][Full Text] [Related]
19. Cross-seeding of WT amyloid-β with Arctic but not Italian familial mutants accelerates fibril formation in Alzheimer's disease.
Liang R; Tian Y; Viles JH
J Biol Chem; 2022 Jul; 298(7):102071. PubMed ID: 35643314
[TBL] [Abstract][Full Text] [Related]
20. The Tottori (D7N) and English (H6R) familial Alzheimer disease mutations accelerate Abeta fibril formation without increasing protofibril formation.
Hori Y; Hashimoto T; Wakutani Y; Urakami K; Nakashima K; Condron MM; Tsubuki S; Saido TC; Teplow DB; Iwatsubo T
J Biol Chem; 2007 Feb; 282(7):4916-4923. PubMed ID: 17170111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
